3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
8
Uterine Cervical Dysplasia
3
Papillomavirus Infections
2
Neoplasms
2
Genital Diseases
2
Atypical Squamous Cells of the Cervix
2
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Squamous Intraepithelial Lesions
1
Sexually Transmitted Diseases, Viral
1
Sexually Transmitted Diseases
1
Precancerous Conditions
1
Papilloma
1
Neoplasms, Squamous Cell
1
Neoplasms, Glandular and Epithelial
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Female Urogenital Diseases and Pregnancy Complications
1
Cervical Intraepithelial Neoplasia Grade 2/3
1
Interventions
ranpirnase
1
VP-102
1
Therapies, Investigational
1
Imiquimod
1
Gels
1
Colposcopy
1
Cantharidin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Sexually Transmitted Diseases
×
Colposcopy
×
Clear all
NCT07281599
2026-02-02
EQUIP
Qurasense
Phase NA
Recruiting
450 enrolled